GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International, Inc. (FRA:HIY1) » Definitions » Piotroski F-Score

Heartware International, (FRA:HIY1) Piotroski F-Score : 2 (As of May. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Heartware International, Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Heartware International, has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Heartware International,'s Piotroski F-Score or its related term are showing as below:

FRA:HIY1' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 2

During the past 10 years, the highest Piotroski F-Score of Heartware International, was 6. The lowest was 1. And the median was 4.


Heartware International, Piotroski F-Score Historical Data

The historical data trend for Heartware International,'s Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International, Piotroski F-Score Chart

Heartware International, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.00 6.00 5.00 2.00

Heartware International, Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 2.00 2.00 1.00 2.00

Competitive Comparison of Heartware International,'s Piotroski F-Score

For the Medical Devices subindustry, Heartware International,'s Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartware International,'s Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heartware International,'s Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Heartware International,'s Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun16) TTM:Last Year (Jun15) TTM:
Net Income was -26.665 + -0.849 + -15.678 + -9.686 = €-52.9 Mil.
Cash Flow from Operations was 3.019 + -1.271 + -19.925 + -2.847 = €-21.0 Mil.
Revenue was 58.063 + 62.504 + 49.456 + 61.161 = €231.2 Mil.
Gross Profit was 28.669 + 41.363 + 28.784 + 39.956 = €138.8 Mil.
Average Total Assets from the begining of this year (Jun15)
to the end of this year (Jun16) was
(437.169 + 435.223 + 420.055 + 387.32 + 382.141) / 5 = €412.3816 Mil.
Total Assets at the begining of this year (Jun15) was €437.2 Mil.
Long-Term Debt & Capital Lease Obligation was €171.0 Mil.
Total Current Assets was €237.8 Mil.
Total Current Liabilities was €45.0 Mil.
Net Income was -5.719 + -0.743 + -13.43 + -24.407 = €-44.3 Mil.

Revenue was 53.24 + 59.372 + 64.699 + 65.55 = €242.9 Mil.
Gross Profit was 35.41 + 40.436 + 44.334 + 43.072 = €163.3 Mil.
Average Total Assets from the begining of last year (Jun14)
to the end of last year (Jun15) was
(310.747 + 332.797 + 343.712 + 382.277 + 437.169) / 5 = €361.3404 Mil.
Total Assets at the begining of last year (Jun14) was €310.7 Mil.
Long-Term Debt & Capital Lease Obligation was €166.2 Mil.
Total Current Assets was €305.9 Mil.
Total Current Liabilities was €38.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Heartware International,'s current Net Income (TTM) was -52.9. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Heartware International,'s current Cash Flow from Operations (TTM) was -21.0. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun15)
=-52.878/437.169
=-0.12095551

ROA (Last Year)=Net Income/Total Assets (Jun14)
=-44.299/310.747
=-0.14255648

Heartware International,'s return on assets of this year was -0.12095551. Heartware International,'s return on assets of last year was -0.14255648. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Heartware International,'s current Net Income (TTM) was -52.9. Heartware International,'s current Cash Flow from Operations (TTM) was -21.0. ==> -21.0 > -52.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun16)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun15 to Jun16
=170.975/412.3816
=0.41460385

Gearing (Last Year: Jun15)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun14 to Jun15
=166.229/361.3404
=0.46003436

Heartware International,'s gearing of this year was 0.41460385. Heartware International,'s gearing of last year was 0.46003436. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun16)=Total Current Assets/Total Current Liabilities
=237.8/44.968
=5.28820495

Current Ratio (Last Year: Jun15)=Total Current Assets/Total Current Liabilities
=305.872/38.747
=7.89408212

Heartware International,'s current ratio of this year was 5.28820495. Heartware International,'s current ratio of last year was 7.89408212. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Heartware International,'s number of shares in issue this year was 0. Heartware International,'s number of shares in issue last year was 0. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=138.772/231.184
=0.60026645

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=163.252/242.861
=0.67220344

Heartware International,'s gross margin of this year was 0.60026645. Heartware International,'s gross margin of last year was 0.67220344. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun15)
=231.184/437.169
=0.52882066

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun14)
=242.861/310.747
=0.78153932

Heartware International,'s asset turnover of this year was 0.52882066. Heartware International,'s asset turnover of last year was 0.78153932. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Heartware International, has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Heartware International,  (FRA:HIY1) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Heartware International, Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Heartware International,'s Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International, (FRA:HIY1) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Heartware International, (FRA:HIY1) Headlines

No Headlines